ACM
AERI
Asymmetry Capital Management’s Aerie Pharmaceuticals, Inc. AERI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-62,507
| Closed | -$1.51M | – | 40 |
|
|
2019
Q4 | $1.51M | Buy |
+62,507
| New | +$1.51M | 2.71% | 15 |
|
|
2019
Q2 | – | Sell |
-71,675
| Closed | -$3.41M | – | 37 |
|
|
2019
Q1 | $3.41M | Buy |
71,675
+14,189
| +25% | +$674K | 5.69% | 7 |
|
|
2018
Q4 | $2.08M | Sell |
57,486
-15,484
| -21% | -$559K | 5.73% | 5 |
|
|
2018
Q3 | $4.49M | Buy |
72,970
+23,214
| +47% | +$1.43M | 4.15% | 6 |
|
|
2018
Q2 | $3.36M | Sell |
49,756
-19,920
| -29% | -$1.35M | 3.3% | 10 |
|
|
2018
Q1 | $3.78M | Buy |
69,676
+29,346
| +73% | +$1.59M | 4.73% | 5 |
|
|
2017
Q4 | $2.41M | Buy |
40,330
+22,355
| +124% | +$1.34M | 3.27% | 10 |
|
|
2017
Q3 | $874K | Sell |
17,975
-7,489
| -29% | -$364K | 1.01% | 29 |
|
|
2017
Q2 | $1.34M | Sell |
25,464
-23,336
| -48% | -$1.23M | 1.59% | 23 |
|
|
2017
Q1 | $2.21M | Sell |
48,800
-15,295
| -24% | -$694K | 3.09% | 15 |
|
|
2016
Q4 | $2.43M | Sell |
64,095
-86,556
| -57% | -$3.28M | 4.51% | 11 |
|
|
2016
Q3 | $5.69M | Buy |
150,651
+66,625
| +79% | +$2.51M | 9.89% | 2 |
|
|
2016
Q2 | $1.48M | Sell |
84,026
-56,561
| -40% | -$996K | 2.71% | 15 |
|
|
2016
Q1 | $1.71M | Buy |
140,587
+54,692
| +64% | +$665K | 4.46% | 10 |
|
|
2015
Q4 | $2.09M | Buy |
85,895
+61
| +0.1% | +$1.49K | 3.16% | 13 |
|
|
2015
Q3 | $1.52M | Buy |
+85,834
| New | +$1.52M | 3.39% | 13 |
|